NCT00752102 - Vitamin D and Coronary Calcification Study | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

September 30, 2008

Primary Completion Date

October 31, 2013

Study Completion Date

October 31, 2013

Conditions

Chronic Kidney DiseaseVitamin D DeficiencyCoronary CalcificationDisorders of Calcium and Bone Metabolism

Interventions

DRUG

Calcitriol (Rocaltrol®)

Subjects taking calcitriol will be started at 0.25 mcg 3x/week and titrated up during the next visit according to PTH levels. If at the 12 week visit, PTH is still not at goal, then calcitriol will be increased to 0.5 mcg 3x/week.

DRUG

Paricalcitol

Subjects taking paricalcitol will be started at 2 mcg 3x/week and titrated up during the next visit according to PTH levels. If at the 12 week visit, PTH is still not at goal, then paricalcitol will be increased to 4 mcg 3x/week.

Trial Locations (1)

19107

Hospital of the University of Pennsylvania, Philadelphia